Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Holly M. Micolochick Steuer"'
Autor:
Kristi Fan, Andrea Cuconati, Robbin Burns, Xiaowei Teng, Amy C.H. Lee, Nagraj Mani, Ellen Evangelista, Bruce D. Dorsey, Sunny Tang, Salam Kadhim, Roseann Kowalski, Angela Miller, Troy Harasym, Janet R. Phelps, Kim Stever, Andrzej Ardzinski, Alice H. Li, Chris Pasetka, Rene Rijnbrand, Andrew G. Cole, Holly M. Micolochick Steuer, Stephen P. Reid, Steven G. Kultgen, Michael J. Sofia, Xiaohe Wang, Tim T. Chiu, Sara A. Majeski, Fang Guo
Publikováno v:
Antiviral research. 197
AB-506, a small-molecule inhibitor targeting the HBV core protein, inhibits viral replication in vitro (HepAD38 cells: EC50 of 0.077 μM, CC50 > 25 μM) and in vivo (HBV mouse model: ∼3.0 log10 reductions in serum HBV DNA compared to the vehicle co
Autor:
Gotchev Dimitar B, Timothy M. Block, Tianlun Zhou, Xiaohe Wang, Jeffrey D. Branson, Rene Rijnbrand, Tim T. Chiu, Michael J. Sofia, Chris B. Moore, Fang Guo, Hongyan Liang, Troy Harasym, Bruce D. Dorsey, Min Gao, Siddhartha Rawat, Amy C.H. Lee, Liren Sun, Bailey Lauren Danielle, Fei Liu, Andy Cuconatti, Holly M. Micolochick Steuer, Andrew S. Kondratowicz
Publikováno v:
Antiviral Research. 149:191-201
In pursuit of novel therapeutics targeting the hepatitis B virus (HBV) infection, we evaluated a dihydroquinolizinone compound (DHQ-1) that in the nanomolar range reduced the production of virion and surface protein (HBsAg) in tissue culture. This co
Autor:
Richeng Mao, Bruce D. Dorsey, Andrew G. Cole, Quanxin Long, Alice H. L. Li, Sunny Tang, Rene Rijnbrand, Troy Harasym, Ellen Evangelista, Xiaohe Wang, Nicholas M. Snead, Kevin McClintock, Sara A. Majeski, Haitao Guo, Nagraj Mani, Kyle D. Cobarrubias, Stephen P. Reid, Fang Guo, Holly M. Micolochick Steuer, Janet R. Phelps, Steven G. Kultgen, Andrea Cuconati, Ju-Tao Guo, Qiong Zhao, Amy C.H. Lee, Salam Kadhim, Kim Stever, Kristi Fan, Andrzej Ardzinski, Michael J. Sofia
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
AB-423 is a member of the sulfamoylbenzamide (SBA) class of hepatitis B virus (HBV) capsid inhibitors in phase 1 clinical trials. In cell culture models, AB-423 showed potent inhibition of HBV replication (50% effective concentration [EC 50 ] = 0.08
Autor:
Xiaohe Wang, Rose Kowalski, Holland Richard J, Lorne R. Palmer, Michael J. Sofia, Andrzej Ardzinski, Hui Huang, Emily P. Thi, Andrew S. Kondratowicz, Amy C.H. Lee, Xin Ye, Chris Pasetka, Holly M. Micolochick Steuer, Andrea Cuconati, Rene Rijnbrand
Publikováno v:
Journal of Hepatology. 70:e471
Autor:
Haiying Bao, Angela M. Lam, Shalini Bansal, Byoung-Kwon Chun, Michael J. Sofia, Holly M. Micolochick Steuer, Jinfa Du, Ying Jiang, Donghui Bao, Eisuke Murakami, Bruce S. Ross, Christine Espiritu, Michael J. Otto, Phillip A. Furman, Hai-Ren Zhang, P. Ganapati Reddy, Congrong Niu
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:5924-5929
The 3',5'-cyclic phosphate prodrug 9-[β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methylribofuranosyl]-2-amino-6-ethoxypurine, PSI-352938 1, has demonstrated promising anti-HCV efficacy in vitro and in human clinical trials. A structure-activity relationship
Autor:
Holly M. Micolochick Steuer, Veronique Zennou, Christine Espiritu, Angela M. Lam, Shalini Bansal, Phillip A. Furman, Michael J. Otto
Publikováno v:
Journal of Virology. 85:12334-12342
PSI-352938, a cyclic phosphate nucleotide, and PSI-353661, a phosphoramidate nucleotide, are prodrugs of β- d -2′-deoxy-2′-α-fluoro-2′-β- C -methylguanosine-5′-monophosphate. Both compounds are metabolized to the same active 5′-triphosph
Autor:
Holly M. Micolochick Steuer, Donghui Bao, Wonsuk Chang, Bruce S. Ross, Angela M. Lam, Shalini Bansal, Dhanapalan Nagarathnam, Michael J. Otto, P. Ganapati Reddy, Meg Keilman, Byoung-Kwon Chun, Congrong Niu, Hai-Ren Zhang, Rachakonda Suguna, Christine Espiritu, Phillip A. Furman, Jinfa Du, Michael J. Sofia
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 20:7376-7380
A series of novel 2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs were synthesized and evaluated for their in vitro anti-HCV activity and safety. These prodrugs demonstrated a 10-100-fold greater potency than th
Autor:
Jinfa Du, Angela M. Lam, Shalini Bansal, Rachakonda Suguna, Congrong Niu, Meg Keilman, Michael J. Otto, Donghui Bao, Bruce S. Ross, Peiyuan Wang, Dhanapalan Nagarathnam, Wonsuk Chang, Holly M. Micolochick Steuer, Michael J. Sofia, Hai-Ren Zhang, Phillip A. Furman, P. Ganapati Reddy, Christine Espiritu
Publikováno v:
Journal of Medicinal Chemistry. 53:7202-7218
Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies. β-d-2'-Deoxy-2'-α-fluor
Autor:
David N. Frick, Dhanapalan Nagarathnam, Congrong Niu, Angela M. Lam, Donald F. Smee, Holly M. Micolochick Steuer, Meg Keilman, Justin G. Julander, Julie A. Heck, Christine Espiritu, Haiying Bao, Nigel Bourne, Phillip A. Furman, Veronique Zennou, Eisuke Murakami, Michael J. Otto, Bruce S. Ross, Peiyuan Wang, Michael J. Sofia, John D. Morrey
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:3187-3196
The hepatitis C virus (HCV) NS5B RNA polymerase facilitates the RNA synthesis step during the HCV replication cycle. Nucleoside analogs targeting the NS5B provide an attractive approach to treating HCV infections because of their high barrier to resi
Autor:
E. Evangelista, A.H.L. Li, B.D. Dorsey, Rene Rijnbrand, Andrea Cuconati, A. Cole, J.R. Phelps, L. Bailey, Amy C.H. Lee, K. Kwak, T. Chiu, J. Pan, S. Tang, T.O. Harasym, S.G. Kultgen, X. Teng, A. Jarosz, Nagraj Mani, A. Shapiro, S. Majeski, D. Gotchev, K. Mcclintock, Andrew S. Kondratowicz, M. Wong, S. Kadhim, R. Burns, Chris Pasetka, Holly M. Micolochick Steuer, K. Stever, Andrzej Ardzinski, Michael J. Sofia
Publikováno v:
Journal of Hepatology. 68:S17